Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant stateGloria V. Echeverria, Helen Piwnica‐Worms, Zhongqi Ge et al.|Science Translational Medicine|2019Cited by 316
High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancerGloria V. Echeverria, Helen Piwnica‐Worms, Emily Powell et al.|Nature Communications|2018Cited by 149
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast CancerMeenakshi Anurag, Matthew J. Ellis, Eric J. Jaehnig et al.|Cancer Discovery|2022Cited by 139
Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatmentMokryun L. Baek, Gloria V. Echeverria|Oncogene|2023Cited by 77
Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancerReid T. Powell, Helen Piwnica‐Worms, Abena B. Redwood et al.|Scientific Reports|2020Cited by 22